The Trump administration’s deep cuts to HIV/AIDS funding have left many countries struggling to maintain prevention and treatment programs.
But Thailand stands out. It funds 91% of its own HIV/AIDS response and supports community outreach led by marginalized groups like sex workers and LGBTQ individuals.
Thailand’s local production of generic HIV drugs since 1993 has lowered costs and built resilience. Other countries like Botswana and Kenya are creating their own drug procurement systems. The African Union plans to buy medications as a bloc to negotiate better prices.
Thailand also integrates HIV services into its universal health coverage, covering prevention and treatment fully. Experts say this strong local ownership offers lessons for other nations facing funding gaps after U.S. support declines.
Read more:
